GlassScriptPhysician profile
Lisa Huang
NPI 1699903625
$2,273.37
in general payments reported to CMS, 2019-2025
22 companies · $237 in 2025
The $237 reported for 2025 was more than what 79% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,072 · 2020: $418 · 2022: $57.80 · 2023: $102 · 2024: $386 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $724.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $423.94 | 2024-2025 | Imfinzi |
| Mylan Specialty L.P. | $315.86 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $284.97 | 2019-2022 | |
| Allergan, INC. | $208.30 | 2019-2020 | |
| Stryker Corporation | $154.98 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $114.18 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $107.90 | 2019-2020 | |
| Beigene USA, INC. | $102.32 | 2023 | Brukinsa |
| Amgen INC. | $92.71 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $92.27 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $66.61 | 2019 | |
| Ucb, INC. | $50.48 | 2019 | |
| Astellas Pharma US INC | $45.22 | 2019 | |
| Alexion Pharmaceuticals, INC. | $43.62 | 2024-2025 | Ultomiris |
| Insmed, INC. | $30.50 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $28.52 | 2020 | |
| Biomerieux INC | $22.94 | 2019 | |
| Sanofi-Aventis U.S. LLC | $19.22 | 2019 | |
| Portola Pharmaceuticals, LLC | $18.81 | 2019 | |
| Resmed Corp | $18.09 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $17.83 | 2020 | |
| Pharming Healthcare, INC. | $14.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.